[1. Jaenson TGT, Jaenson DGE, Eisen L, Petersson E, Lindgren E. Changes in the geographical distribution and abundance of the tick Ixodes ricinus during the past 30 years in Sweden. Parasit Vectors. 2012;10:5-8. DOI: 10.1186/1756-3305-5-8.10.1186/1756-3305-5-8]Search in Google Scholar
[2. Berglund J, Eitrem R, Ornstein K. An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med. 1995;333:1319-27. DOI: 10.1056/ NEJM19951116333200410.1056/NEJM199511163332004]Search in Google Scholar
[3. Strle F. Lyme borreliosis in Slovenia. Zentralbl Bakteriol. 1999;289(5-7):643-52. DOI: 10.1016/S0934-8840(99)80023-110.1016/S0934-8840(99)80023-1]Search in Google Scholar
[4. Zöldi V, Juhász A, Nagy C, Papp Z, Egyed L. Tickborne encephalitis and Lyme disease in Hungary: the epidemiological situation between 1998 and 2008. Vector Borne Zoonotic Dis. 2013 Apr;13(4):256-65. DOI: 10.1089/vbz.2011.090510.1089/vbz.2011.090523428090]Search in Google Scholar
[5. Mukhacheva TA, Kovalev SY. Multilocus sequence analysis of Borrelia burgdorferi s.l. in Russia. Ticks Tick Borne Dis. 2013 Jun;4(4):275-9. DOI: 10.1016/j. ttbdis.2013.02.004]Search in Google Scholar
[6. Coipan EC, Vladimirescu AF. Ixodes ricinus ticks (Acari: Ixodidae): vectors for Lyme disease spirochetes in Romania. Exp Appl Acarol. 2011;54(3):293-300. DOI: 10.1007/s10493-011-9438-410.1007/s10493-011-9438-421431930]Search in Google Scholar
[7. Kiss T, Cadar D, Krupaci AF, Bordeanu A, Brudaşcă GF, Mihalca AD, et al. Serological reactivity to Borrelia burgdorferi sensu lato in dogs and horses from distinct areas in Romania. Vector Borne Zoonotic Dis. 2011;11(9):1259-62. DOI: 10.1089/vbz.2010.025410.1089/vbz.2010.025421612524]Search in Google Scholar
[8. Hristea A, Hristescu S, Ciufecu C, Vasile A. Seroprevalence of Borrelia burgdorferi in Romania. Eur J Epidemiol. 2001;17(9):891-6. DOI: 10.1023/A:101560072990010.1023/A:1015600729900]Search in Google Scholar
[9. Stanek G, O’Connell S, Cimmino M, Aberer E, Kristoferitsch W, Granstrom M, et al. European Union Concerted Action on Risk Assessment in Lyme borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr; 1996;108(23):741-7.]Search in Google Scholar
[10. Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, et al. The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America. Clinical Infectious Diseases. 2006;43(9):1089-134. DOI: 10.1086/50866710.1086/50866717029130]Search in Google Scholar
[11. Schulte-Spechtel U, Hillermann R, Liegl G, Wilske B, Fingerle V. Improvement of Lyme Borreliosis Serodiagnosis by a Newly Developed Recombinant Immunoglobulin G (IgG) and IgM Line Immunoblot Assay and Addition of VlsE and DbpA Homologues Gereon Goettner. J Clin Microbiol. 2005;43(8):3602-9. DOI: 10.1128/JCM.43.8.3602-3609.200510.1128/JCM.43.8.3602-3609.2005123398416081885]Search in Google Scholar
[12. Rosner B. Fundamentals of Biostatistics, 7th Edition. Duxbury Press, 2010.]Search in Google Scholar
[13. Piesman J, Gern L. Lyme borreliosis in Europe and North America. Parasitology. 2004;129 Suppl: S191-220. DOI: 10.1017/S003118200300469410.1017/S0031182003004694]Search in Google Scholar
[14. Tijsse-Klasen E, Pandak N, Hengeveld P, Takumi K, Koopmans MPG, Sprong H. Ability to cause erythema migrans differs between Borrelia burgdorferi sensu lato isolates. Parasit Vectors. 2013;6:23. DOI: 10.1186/1756-3305-6-2310.1186/1756-3305-6-23359912623339549]Search in Google Scholar
[15. Svihrova V, Hudeckova H, Jesenak M, Schwarzova K, Kostanova Z, Ciznar I. Lyme borreliosis--analysis of the trends in Slovakia1999-2008. Folia Microbiol. 2011;56(3):270-5. DOI: 10.1007/s12223-011-0036-y10.1007/s12223-011-0036-y21607749]Search in Google Scholar
[16. Bartosik K, Lachowska-Kotowska P, Szymańska J, Pabis A, Buczek A. Lyme borreliosis in south-eastern Poland: relationships with environmental factors and medical attention standards. Ann Agric Environ Med. 2011;18(1):131-7.]Search in Google Scholar
[17. Van Dam AP, Kuiper H, Vos K, Widjojokusumo A, de Jongh BM, Spanjaard L, et al. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis. 1993 Oct;17(4):708-17. DOI: 10.1093/clinids/17.4.70810.1093/clinids/17.4.7087903558]Search in Google Scholar
[18. Strle F, Nadelman RB, Cimperman J, Nowakowski J, Picken RN, Schwartz I, et al. Comparison of culture- confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia. Ann Intern Med. 1999;130(1):32-6. DOI: 10.7326/0003-4819-130-1-199901050-0000610.7326/0003-4819-130-1-199901050-000069890847]Search in Google Scholar
[19. Richter D, Klug B, Spielman A, Matuschka FR. Adaptation of Diverse Lyme Disease Spirochetes in a Natural Rodent Reservoir Host. Infect Immun 2004;72(4):2442-4. DOI: 10.1128/IAI.72.4.2442-2444.200410.1128/IAI.72.4.2442-2444.200437519115039378]Search in Google Scholar
[20. Strle F, Ružić-Sabljić E, Logar M, Maraspin V, Lotrič-Furlan S, Cimperman J, et al. Comparison of erythema migrans caused by Borrelia burgdorferi and Borrelia garinii. Vector Borne Zoonotic Dis. 2011;11(9):1253-8 DOI: 10.1089/vbz.2010.023010.1089/vbz.2010.023021612533]Search in Google Scholar
[21. Dandache P, Nadelman RB. Erythema migrans. Infect Dis Clin North Am. 2008;22(2):235-60. DOI: 10.1016/j.idc.2007.12.01210.1016/j.idc.2007.12.01218452799]Search in Google Scholar
[22. Stanek G, Wormser GP, Gray J, Strle F. Lyme borreliosis. Lancet. 2012;379(9814):461-73. DOI: 10.1016/ S0140-6736(11)60103-7]Search in Google Scholar
[23. Stupica D, Lusa L, Cerar T, Ružić-Sabljić E, Strle F. Comparison of post-Lyme Borreliosis symptoms in erythema migrans patients with positive and negative Borrelia burgdorferi sensu lato skin culture. Vector Borne Zoonotic Dis. 2011;11(7):883-9. DOI: 10.1089/ vbz.2010.001810.1089/vbz.2010.001821083376]Search in Google Scholar
[24. Glatz M, Golestani M, Kerl H, Müllegger RR. Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients. Arch Dermatol. 2006;142(7):862-8. DOI: 10.1001/archderm.142.7.86210.1001/archderm.142.7.86216847202]Search in Google Scholar
[25. Dattwyler RJ, Luft BJ, Kunkel MJ, Finkel MF, Wormser GP, Rush TJ, et al. Ceftriaxone compared with doxycicline for the treatment of acute disseminated Lyme disease. N Engl J Med. 1997;337(5):289-94. DOI: 10.1056/NEJM19970731337050110.1056/NEJM1997073133705019233865]Search in Google Scholar
[26. Massarotti EM, Luger SW, Rahn DW, Messner RP, Wong JB, Johnson RC, et al. Treatment of early Lyme disease. Am J Med. 1992;92(4):396-403. DOI: 10.1016/0002-9343(92)90270-L10.1016/0002-9343(92)90270-L]Search in Google Scholar
[27. Weber K, Wilske B, Preac-Mursic V, Thurmayr R. Azithromycin versus penicillin V for the treatment of early Lyme borreliosis. Infection. 1993; 21(6):367-372. DOI: 10.1007/BF0172891510.1007/BF01728915]Search in Google Scholar
[28. Nowakowski J, Nadelman RB, Sell R, McKenna D, Cavaliere LF, Holmgren D. et al. Longterm follow-up of patients with culture-confirmed Lyme disease. Am J Med. 2003;115(2):91-6. DOI: 10.1016/S0002-9343(03)00308-510.1016/S0002-9343(03)00308-5]Search in Google Scholar
[29. Wormser, GP, Ramanathan, R, Nowakowski, J, McKenna, D, Holmgren D, Visintainer P, et al. Duration of antibiotic therapy for early Lyme disease. Ann Intern Med.2003;138(9):697-704. DOI: 10.7326/0003-4819-138-9-200305060-0000510.7326/0003-4819-138-9-200305060-0000512729423]Search in Google Scholar
[30. Kalish RA, McHugh G, Granquist J, Shea B, Ruthazer R, Steere AC. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease. Clin Infect Dis. 2001;33(6):780-5. DOI: 10.1086/32266910.1086/32266911512082]Search in Google Scholar
[31. Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B-cells. Science. 2002;298(5601):2199-202. DOI: 10.1126/science.107607110.1126/science.107607112481138]Search in Google Scholar
[32. Aguero Rosenfeld ME, Nowakowski J, Bittker S, CooperD, Nadelman RB, Wormser GP. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol. 1996;34(1):1-9.10.1128/jcm.34.1.1-9.19962287188748261]Search in Google Scholar
[33. Mullegger RR, Glatz M. Is serological follow-up useful for patients with cutaneous Lyme borreliosis? Curr Probl Dermatol. 2009;37:178-82. DOI: 10.1159/000213075 10.1159/00021307519367102]Search in Google Scholar